KONINKLIJKE PHILIPS NV
Company Information
Industry
X-Ray Apparatus & Tubes & Related Irradiation Apparatus
SIC Code
3844
Entity Type
other
SEC Category
Large accelerated filer
State of Incorporation
Netherlands
Country
Netherlands
Business Address
PRINSES IRENESTRAAT 59, AMSTERDAM, , 1077WV
Mailing Address
PRINSES IRENESTRAAT 59, AMSTERDAM, , 1077WV
Phone
31 20 59 77777
Fiscal Year End
1231
EIN
000000000
Financial Overview
FY2025
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 6-K Foreign company current report | March 30, 2026 | View on SEC |
| 6-K Foreign company current report | March 30, 2026 | View on SEC |
| 20-F Foreign company annual report | February 19, 2026 | View on SEC |
| 6-K Foreign company current report | February 19, 2026 | View on SEC |
| 6-K Foreign company current report | February 10, 2026 | View on SEC |
| 6-K Foreign company current report | February 10, 2026 | View on SEC |
| 6-K Foreign company current report | November 4, 2025 | View on SEC |
| 6-K Foreign company current report | July 29, 2025 | View on SEC |
| 6-K Foreign company current report | June 5, 2025 | View on SEC |
| 6-K Foreign company current report | June 4, 2025 | View on SEC |
Annual Reports
20-F
February 19, 2026
- Philips returned to 3% comparable sales growth in 2023, with Adjusted EBITA improving to €1.5 billion (8.2% of sales).
- The Diagnosis & Treatment segment showed strong performance, generating €9.1 billion in sales with 5% comparable growth.
Related Companies
Companies in the same industry (SIC: 3844)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.